| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.074 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |